AIM AIM ImmunoTech Inc.
Price Chart
Executive Summary
AIM ImmunoTech filed a 424B5 to suspend its equity distribution agreement (ATM) with Maxim Group, halting further sales under the current shelf. The suspension removes near-term dilution overhang, but the company has already sold $2.85M of the $3.41M registered, and a simultaneous 8-K revealed a Q1 EPS miss (-$0.57 vs -$0.37) and ongoing financial distress for this $3M market cap micro-cap.
Actionable Insight
The suspension is a temporary positive as it removes immediate ATM overhang, but the company still needs capital and faces deep operating losses. Monitor for any new financing announcements or further dilution restructuring. The stock is highly volatile and fundamentals remain weak.
Key Facts
- Suspends sales under the Equity Distribution Agreement; no further ATM sales until a new prospectus supplement is filed.
- As of May 19, 2026, $2,847,151.09 of common stock had been sold under the EDA (out of $3,409,174 registered).
- Stock price was $0.4080 per share on May 18, 2026.
- 8-K filed same day reports debt extension with Streeterville to June 2027, improved equity ($2.1M vs -$9.8M deficit), and Q1 EPS miss.
- Market cap is approximately $3M, indicating extreme micro-cap risk.
Financial Impact
Removes potential future dilution of up to ~$562k (remaining registered amount). Already sold $2.85M, which is substantial relative to market cap.
Risk Factors
- Further capital needs may force dilutive financing at low prices.
- Debt with Streeterville (amended again) suggests ongoing liquidity pressure.
- Low cash runway and negative earnings per share persist.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-024458 |
| Document: 0001493152-26-024458-index-headers.html | 0001493152-26-024458 |
| Document: 0001493152-26-024458-index.html | 0001493152-26-024458 |
| Document: 0001493152-26-024458.txt | 0001493152-26-024458 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
8-K
| $0.4543 awaiting T+1 | awaiting T+1 | — | $0.4100 (+9.75%) |
|
Jun 10, 2026
2d ago
|
424B5
| $0.4477 awaiting T+1 | awaiting T+1 | — | $0.4100 (+8.42%) |
|
Jun 8, 2026
5d ago
|
Press Release
| $0.4589 awaiting T+1 | awaiting T+1 | — | $0.4100 (−10.66%) |
|
Jun 4, 2026
9d ago
|
8-K
| $0.5900 $0.5200 | ▼ −11.86% | ▼ −9.27% | $0.4100 (−30.51%) |
|
Jun 1, 2026
12d ago
|
Press Release
| $0.9000 $0.8300 | ▼ −7.78% | ▼ −7.92% | $0.4100 (−54.44%) |
|
May 21, 2026
22d ago
|
8-K
| $0.2400 $0.2400 | · 0.00% | ▲ +0.45% | $0.4100 (−70.83%) |
|
May 21, 2026
22d ago
|
424B5
| $0.2400 $0.2400 | · 0.00% | ▲ +0.45% | $0.4100 (−70.83%) |
|
May 20, 2026
23d ago
|
Press Release
| $0.2500 $0.2400 | ▲ +4.00% | ▲ +4.19% | $0.4100 (−64.00%) |
|
May 19, 2026
24d ago
|
424B5
| $0.2500 $0.2400 | ▼ −4.00% | ▼ −4.19% | $0.4100 (+64.00%) |
|
May 19, 2026
25d ago
|
8-K
| $0.4100 $0.2500 | ▼ −39.02% | ▼ −40.06% | $0.4100 (−0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access